OPTILATER: A Cross-Sectional Study Design for Evaluating Long-Term Survival and Care Conditions Among Cancer Survivors in Germany - Summary - DentalSpire

OPTILATER: A Cross-Sectional Study Design for Evaluating Long-Term Survival and Care Conditions Among Cancer Survivors in Germany

  • By

  • C. N. Martin

  • N. De Lazzari

  • J. Kersten

  • K. Claassen

  • C. Jansen

  • K. Kaminski

  • F. Baumann

  • M. Götte

  • S. Palm

  • A. Stang

  • V. Grünwald

  • U. Dirksen

  • M. A. Teufel

  • E.-M. Skoda

  • October 24, 2025

  • 0 min

Share

Objective:

To systematically evaluate the needs of cancer survivors in Germany, focusing on late effects of cancer treatment and the necessary follow-up care for optimal long-term survival.

Key Findings:
  • Increasing number of cancer survivors in Germany, with 4.65 million reported in 2017, highlighting the need for improved care.
  • Many long-term survivors lack information on late effects and follow-up care, which can lead to adverse health outcomes.
  • Disparities in care exist among ethnic minority populations, impacting long-term outcomes and necessitating targeted interventions.
Interpretation:

The study aims to provide evidence-based recommendations for improving survivorship care, particularly for underrepresented groups, to enhance long-term quality of life through targeted interventions.

Limitations:
  • The study does not include medical or therapeutic interventions.
  • Focus is solely on assessing experiences and unmet needs without implementing treatments, which may introduce biases in self-reported data.
Conclusion:

The OPTILATER project seeks to address gaps in survivorship care and inform targeted interventions for cancer survivors in Germany.

Original Source(s)

OPTILATER: A Cross-Sectional Study Design for Evaluating Long-Term Survival and Care Conditions Among Cancer Survivors in Germany

  • by C. N. Martin, N. De Lazzari, J. Kersten, K. Claassen, C. Jansen, K. Kaminski, F. Baumann, M. Götte, S. Palm, A. Stang, V. Grünwald, U. Dirksen, M. A. Teufel, E.-M. Skoda

  • October 24, 2025

Related Content

Predicting survival in oral squamous cell carcinoma via integrated analysis of tumor budding and tertiary lymphoid structures

Glucocorticoids as adjunctive therapy for severe myelosuppression induced by combined immune checkpoint inhibitor and chemotherapy: a case report and literature review

αß T-cell depleted haploidentical stem cell transplantation for pediatric and young adult patients with transfusion-dependent thalassemia